Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns
Author(s) -
Donald H. Chace,
Theodore A. Kalas,
Edwin W. Naylor
Publication year - 2003
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2003.022178
Subject(s) - newborn screening , tandem mass spectrometry , dried blood , metabolite , metabolomics , amino acid analysis , amino acid metabolism , metabolic disease , mass spectrometry , computational biology , chemistry , medicine , computer science , amino acid , chromatography , biochemistry , biology
Over the past decade laboratories that test for metabolic disorders have introduced tandem mass spectrometry (MS/MS), which is more sensitive, specific, reliable, and comprehensive than traditional assays, into their newborn-screening programs. MS/MS is rapidly replacing these one-analysis, one-metabolite, one-disease classic screening techniques with a one-analysis, many-metabolites, many-diseases approach that also facilitates the ability to add new disorders to existing newborn-screening panels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom